false
OasisLMS
ar,zh-CN,zh-TW,en,fr,de,hi,it,ja,es,ur
Login
Catalog
SCAI 2026 Treatment and Management of Complex Peri ...
Medical Therapy for Complex PAD, Dr. Monteleone
Medical Therapy for Complex PAD, Dr. Monteleone
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker, an interventional cardiologist, reviews medical management of peripheral artery disease (PAD), emphasizing that PAD signals high cardiovascular risk. He recommends antiplatelet therapy for all PAD patients, usually aspirin or clopidogrel, not both. For selected patients, low-dose rivaroxaban plus aspirin reduces cardiovascular and limb events, especially after revascularization, though bleeding risk rises. He stresses aggressive lipid lowering with statins and possible PCSK9 inhibitors, which also reduce limb events. He briefly mentions symptom relief options, favoring cilostazol over pentoxifylline, and highlights improved diabetes care, including GLP-1 therapies. Overall: treat PAD as a high-risk vascular disease to save lives and limbs.
Asset Caption
closed captions are computer-generated
Keywords
peripheral artery disease
antiplatelet therapy
rivaroxaban aspirin
statins PCSK9 inhibitors
cilostazol
×
Please select your language
1
English